Clinical Trial Update: Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a 6-month regimen of triptorelin pamoate in adult Chinese men with advanced prostate cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Trelstar LA (triptorelin pamoate)

Snippet

Sponsor: Ipsen | Conditions: Advanced Prostate Cancer, Metastatic Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-09-09